The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)phenyl)-N-(3,4,5-trimethoxyphenyl)acetamide ID: ALA4790509
PubChem CID: 162668583
Max Phase: Preclinical
Molecular Formula: C23H23N5O4
Molecular Weight: 433.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]ccc34)cc2)cc(OC)c1OC
Standard InChI: InChI=1S/C23H23N5O4/c1-30-18-11-16(12-19(31-2)21(18)32-3)27-20(29)10-14-4-6-15(7-5-14)28-23-17-8-9-24-22(17)25-13-26-23/h4-9,11-13H,10H2,1-3H3,(H,27,29)(H2,24,25,26,28)
Standard InChI Key: CJHCJVQXCMYMNE-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
20.8452 -3.7681 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8441 -4.5877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5521 -4.9966 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5503 -3.3593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2589 -3.7645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2637 -4.5831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0438 -4.8316 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5211 -4.1665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0360 -3.5071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5479 -2.5421 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2544 -2.1314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9612 -2.5402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6672 -2.1302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6652 -1.3121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9513 -0.9058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2482 -1.3182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3711 -0.9005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0806 -1.3060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7865 -0.8944 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0841 -2.1232 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.4960 -1.2999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4976 -2.1142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2062 -2.5197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9131 -2.1080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9069 -1.2866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1977 -0.8848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6114 -0.8724 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.6231 -2.5126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.2093 -3.3369 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.5032 -3.7482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6277 -3.3297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3223 -1.2755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
14 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
25 27 1 0
24 28 1 0
23 29 1 0
29 30 1 0
28 31 1 0
27 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 433.47Molecular Weight (Monoisotopic): 433.1750AlogP: 3.91#Rotatable Bonds: 8Polar Surface Area: 110.39Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.31CX Basic pKa: 5.72CX LogP: 3.15CX LogD: 3.14Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.39Np Likeness Score: -1.00
References 1. Lakkaniga NR,Gunaganti N,Zhang L,Belachew B,Frett B,Leung YK,Li HY. (2020) Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation., 206 [PMID:32823007 ] [10.1016/j.ejmech.2020.112691 ]